Experimental Drug for Cushing’s Syndrome Gets Orphan Drug Designation
source: pixabay.com

Experimental Drug for Cushing’s Syndrome Gets Orphan Drug Designation

According to a story from 4-traders.com, the pharmaceutical company SteroTherapeutics recently announced that its drug candidate ST-002 was awarded Orphan Drug Designation by the U.S. Food and Drug Administration (FDA).…

Continue Reading Experimental Drug for Cushing’s Syndrome Gets Orphan Drug Designation